Article Information
History
- September 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Vidyasagar Devaprasad Dedeepiya1,
- Chockanathan Vetrievel2,
- Nobunao Ikewaki3,4,
- Naoki Yamamoto5,
- Hiroto Kawashima6,
- Koji Ichiyama7,
- Rajappa Senthilkumar7,8,
- Senthilkumar Preethy8 and
- Samuel JK Abraham1,7,9,10,11,*
- 1Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
- 2Be Well Hospitals, Chennai, Tamil Nadu, India
- 3Dept. of Medical Life Science, Kyushu University of Health and Welfare, Japan
- 4Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan
- 5National Centre for Global health and Medicine (NCGM), Chiba, Japan
- 6Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
- 7Antony-Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., Kofu, Japan
- 8Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India
- 9R & D, Sophy Inc., Japan
- 10Centre for Advancing Clinical Research (CACR), University of Yamanashi - School of Medicine, Chuo, Japan
- 11Levy-Jurgen Transdisciplinary Exploratory (LJTE), Global Niche Corp., Wilmington, DE, USA
- ↵*Corresponding author information:
Dr. Samuel JK Abraham, II Department of Surgery & CACR, University of Yamanashi, Faculty of Medicine Address for correspondence: 3-8, Wakamatsu, Kofu, 400-0866, Yamanashi, Japan Email id- drsam{at}nichimail.jp; Alternate email id: drspp{at}nichimail.jp Fax: +81-55-235-7569
Posted September 08, 2023.
Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial
